FDA Approves Lumisight for Enhanced Cancer Detection during Lumpectomy

424 Views

Emedinexus 15 April 2025

The FDA has approved Lumisight for adults with breast cancer to aid in detecting cancerous tissue during lumpectomy surgery. Administered intravenously before the procedure, this fluorescent imaging drug helps identify remaining cancer in the resection cavity, potentially improving surgical outcomes and reducing the need for repeat surgeries.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.